Tech Company Financing Transactions
ZS Pharma Funding Round
On 10/26/2012, ZS Pharma received $46 million in Series C financing from Alta Partners, 3x5 Special Opportunity Partners and Devon Park Bioventures.
Transaction Overview
Alta Partners (Lead Investor) (Robert Alexander)
3x5 Special Opportunity Partners
Devon Park Bioventures (Marc Ostro)
RiverVest Venture Partners (John McKearn)
Company Information
Coppell, TX 75019
USA
Management Team
Browse more venture capital transactions:
Prev: 10/26/2012: Verax Biomedical venture capital transaction
Next: 10/26/2012: Udacity venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs